美聯新材(300586.SZ):與七彩化學等簽訂戰略合作協議 共同推進鈉離子電池產業化進程
格隆匯1月6日丨美聯新材(300586.SZ)公佈,公司及其控股子公司遼寧美彩新材料有限公司與湖南立方新能源科技有限責任公司、七彩化學(300758.SZ)就各方充分發揮各自優勢,資源共享,共同推進鈉離子電池產業化進程事項達成了戰略合作共識,於2023年1月6日在汕頭市簽訂了《戰略合作協議》。
各方技術團隊應充分發揮各自在普魯士藍(白)電池級材料領域的技術優勢,全力以赴,共同就鈉離子電池正負極材料——普魯士藍(白)的相關性能、規格參數及生產工藝等內容展開合作研發、實驗,形成溝通反饋機制,共同提升技術指標以推進魯士藍(白)材料鈉離子電池的產業化進程,首期合作期限為10年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.